宣称“可降血脂、替代药物”，红曲米产品被包装成降脂神药

Core Viewpoint - The article discusses the misleading marketing of OWV red yeast rice capsules, which claim to lower cholesterol and can replace traditional medications, despite being classified as dietary supplements rather than drugs [1][6][16]. Group 1: Product Claims and Marketing - OWV red yeast rice capsules are marketed as a natural alternative to statins, with claims of being 50 times safer than traditional medications [1][5]. - Customer testimonials on e-commerce platforms suggest significant improvements in cholesterol levels after using the product [2][5]. - The product's promotional materials emphasize its effectiveness in improving cardiovascular health and reducing blood lipid levels, targeting middle-aged consumers [5][8]. Group 2: Regulatory and Legal Concerns - The product is classified as a dietary supplement, and its marketing claims may violate Chinese advertising laws by suggesting it can treat medical conditions [6][16]. - Legal experts indicate that the promotion of the product as a substitute for prescription medications could be considered misleading and illegal under Chinese law [16][17]. - The claims of endorsements from prestigious medical awards and organizations are misleading, as the product has not received such certifications [16][17]. Group 3: Medical Perspective - Medical professionals warn that while red yeast rice may have some cholesterol-lowering effects, it cannot replace statin medications, which have proven efficacy and safety [12][13]. - Studies indicate that dietary supplements like red yeast rice may not provide significant benefits compared to traditional medications, with some research showing no notable reductions in cholesterol levels [13]. - The potential risks associated with red yeast rice, including liver damage, highlight the importance of using it as a complementary treatment rather than a primary one [12][14]. Group 4: Consumer Rights and Recourse - Consumers misled by the product's claims can seek refunds, report to regulatory authorities, or pursue legal action for damages [20]. - The cross-border nature of the product's sales complicates enforcement of consumer rights, as the companies involved are based in Hong Kong [19][20].